All News

Kisqali Femara Co-Pack (ribociclib tablets; letrozole tablets) treats hormone receptor-positive, human epidermal growth factor receptor-2 negative breast cancer in post-menopausal patients.

A malaria protein combined with an anti-cancer drug shows promise against chemotherapy-resistant bladder cancer.

Buprenorphine could potentially have better treatment outcomes in infants with neonatal abstinence syndrome (NAS) than traditionally used oral morphine, according to a study recently published in the New England Journal of Medicine.

Combination treatment shows promise fighting bladder cancer.

Top news of the day from across the healthcare landscape.

Data show communication failure accounted for 71% of serious or life-threatening errors related to medication errors.

Radicava is an intravenous infusion for the treatment of amyotrophic lateral sclerosis (ALS).

At least 1 adverse event reported with brompheniramine, chlorpheniramine, dextromethorphan, diphenhydramine, doxylamine, guaifenesin, pseudoephedrine, and phenylephrine in children under age 12.

The Kisqali Femara Co-Pack is the only approved combination pack that includes 2 prescription drugs used to treat breast cancer.

The competition for positions in the world of pharmacy is fierce.

There are some key differences between Japanese and U.S. health care

The product is packaged with UPC code 0058049984 and can be identified by GEC Laxoplex.

The current outlook for biosimilar manufacturers shows significant promise.

Patients with HIV on ART may have high viral levels, immune activation, and inflammation.

Steroids discovered in dietary supplements distributed from 2015 to 2017.

Cellular mechanism may present treatment target for multiple sclerosis.

Many adverse events associated with OTC cold medications are related to accidental unsupervised ingestions or dosing errors, which means better education from pharmacists and other health care providers may help reduce these events, according to a study published in Pediatrics this month.

Regular low-dose aspirin use associated with a lower risk of breast cancer.

Top news of the day from across the health care landscape.

A majority of the children with C. difficile were prescribed at least 1 antibiotic in the 12 weeks leading up to their diagnosis.

Top news of the day from across the healthcare landscape.

Most children with asthma have symptoms that are controlled through low to moderate doses of inhaled corticosteroids.

Every health care system encourages its workers to receive an annual influenza vaccination.

I was asked these questions as a student, now I'm giving you the answers.

The first new FDA approval for ALS in 22 years, here's what you should know.

Top articles of the week from The American Journal of Pharmacy Benefits.

Suppressing MAFK pathway in tumor cells may slow spread of aggressive breast cancer.

The FDA has approved edaravone (Radicava, Mitsubishi Tanabe Pharma America) for the treatment of amyotrophic lateral sclerosis (ALS), the first new ALS therapy approved by the FDA in several years.

Manufacturers and payers face regulatory and operational barriers for value-based contracts.